Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | PLA2G2A | P14555 | 3/20 | 0.34 |
| ▸ | PLA2G4A | P47712 | 3/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.33 |
| ▸ | HPSE | Q9Y251 | 1/20 | 0.32 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.32 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26080575 | 0.99 | KDM4E (0.38) | KDM4EATML3MBTL1PLA2G2APLA2G4A | |
| SCHEMBL20290898 | 0.96 | PDE10A (0.34) | KDM4EATML3MBTL1PLA2G2APLA2G4A | |
| SCHEMBL20291332 | 0.96 | PDE10A (0.34) | KDM4EATML3MBTL1PLA2G2APLA2G4A | |
| SCHEMBL20291225 | 0.96 | PDE10A (0.34) | KDM4EATML3MBTL1PLA2G2APLA2G4A | |
| SCHEMBL21191834 | 0.96 | ATM (0.37) | KDM4EATML3MBTL1PLA2G2APLA2G4A | |
| SCHEMBL19239453 | 0.96 | KDM4E (0.35) | KDM4EATML3MBTL1PLA2G2APLA2G4A | |
| SCHEMBL27253689 | 0.96 | KDM4E (0.35) | KDM4EATML3MBTL1PLA2G2APLA2G4A | |
| SCHEMBL21707317 | 0.96 | KDM4E (0.40) | KDM4EATML3MBTL1LMNASMN1; SMN2 | |
| SCHEMBL20291270 | 0.95 | PDE10A (0.34) | KDM4EATML3MBTL1PLA2G2APLA2G4A | |
| SCHEMBL20290670 | 0.95 | PDE10A (0.34) | KDM4EATML3MBTL1PLA2G2APLA2G4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230312538-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LT MATERIALS CO., LTD. (KR) | 2023-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230312538-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | CRY1, CYP1A1, CYP1B1 | KDM4E 2539/4885ATM 3031/4885L3MBTL1 1591/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.